Hypertension:家庭血压变异性或可预测认知减退

2014-04-04 高晓方 译 医学论坛网

日本一项研究表明,由于家庭血压测定可提供每日血压变异性信息,因此可用于预测未来认知减退。论文于3月31日在线发表于《高血压》(Hypertension)。此项前瞻性研究共纳入485例平均年龄为63岁的受试者。基线时受试者均无认知减退。测定受试者家庭血压,并计算每日血压变异性。评估家庭血压对认知减退的预测价值,以及每日血压变异性能否更好预测认知减退。中位随访时间为7.8年。结果显示,46例受试者在随

日本一项研究表明,由于家庭血压测定可提供每日血压变异性信息,因此可用于预测未来认知减退。论文于3月31日在线发表于《高血压》(Hypertension)。

此项前瞻性研究共纳入485例平均年龄为63岁的受试者。基线时受试者均无认知减退。测定受试者家庭血压,并计算每日血压变异性。评估家庭血压对认知减退的预测价值,以及每日血压变异性能否更好预测认知减退。中位随访时间为7.8年。

结果显示,46例受试者在随访期间出现认知减退。家庭收缩压升高与认知减退具有显著相关性(比值比[OR] 1.48),常规收缩压则与认知减退无显著相关性(OR 1.24)。在模型中纳入家庭收缩压后,收缩压每日变异性与认知减退显著相关;尽管家庭收缩压OR仍为阳性,但显著性消失。

原始出处:


Matsumoto A1, Satoh M, Kikuya M, Ohkubo T, Hirano M, Inoue R, Hashimoto T, Hara A, Hirose T, Obara T, Metoki H, Asayama K, Hosokawa A, Totsune K, Hoshi H, Hosokawa T, Sato H, Imai Y.Day-to-Day Variability in Home Blood Pressure Is Associated With Cognitive Decline: The Ohasama Study.Hypertension. 2014 Mar 31.

相关阅读:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1954720, encodeId=91111954e2068, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon May 19 03:48:00 CST 2014, time=2014-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038487, encodeId=211a203848ed4, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri Sep 19 16:48:00 CST 2014, time=2014-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725587, encodeId=5f7e1e2558733, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun May 18 10:48:00 CST 2014, time=2014-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342298, encodeId=86aa1342298aa, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501041, encodeId=e3401501041b8, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1954720, encodeId=91111954e2068, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon May 19 03:48:00 CST 2014, time=2014-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038487, encodeId=211a203848ed4, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri Sep 19 16:48:00 CST 2014, time=2014-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725587, encodeId=5f7e1e2558733, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun May 18 10:48:00 CST 2014, time=2014-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342298, encodeId=86aa1342298aa, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501041, encodeId=e3401501041b8, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1954720, encodeId=91111954e2068, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon May 19 03:48:00 CST 2014, time=2014-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038487, encodeId=211a203848ed4, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri Sep 19 16:48:00 CST 2014, time=2014-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725587, encodeId=5f7e1e2558733, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun May 18 10:48:00 CST 2014, time=2014-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342298, encodeId=86aa1342298aa, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501041, encodeId=e3401501041b8, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=)]
    2014-05-18 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1954720, encodeId=91111954e2068, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon May 19 03:48:00 CST 2014, time=2014-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038487, encodeId=211a203848ed4, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri Sep 19 16:48:00 CST 2014, time=2014-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725587, encodeId=5f7e1e2558733, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun May 18 10:48:00 CST 2014, time=2014-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342298, encodeId=86aa1342298aa, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501041, encodeId=e3401501041b8, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1954720, encodeId=91111954e2068, content=<a href='/topic/show?id=d62991211f1' target=_blank style='color:#2F92EE;'>#认知减退#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91211, encryptionId=d62991211f1, topicName=认知减退)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon May 19 03:48:00 CST 2014, time=2014-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038487, encodeId=211a203848ed4, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Fri Sep 19 16:48:00 CST 2014, time=2014-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725587, encodeId=5f7e1e2558733, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun May 18 10:48:00 CST 2014, time=2014-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1342298, encodeId=86aa1342298aa, content=<a href='/topic/show?id=34cb381023e' target=_blank style='color:#2F92EE;'>#变异#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38102, encryptionId=34cb381023e, topicName=变异)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78c32500188, createdName=12498dabm77暂无昵称, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501041, encodeId=e3401501041b8, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Sun Apr 06 07:48:00 CST 2014, time=2014-04-06, status=1, ipAttribution=)]

相关资讯

Hypertension:家庭血压变异预测转归无显著优势

  研究表明,在普通人群中,由家庭血压衍生的血压变异性新指数在转归并未较平均收缩压增加转归预测价值。论文于2012年11月19日在线发表于《高血压》(Hypertension)。   此项研究共纳入2421例受试者(平均年龄58.6岁,女性60.9%,经治者27.1%)。入组时受试者通过示波装置测定家庭血压。利用多变量校正Cox模型评估平均收缩压和相应变异性的独立预测价值。上述变异性通过独立于平